期刊文献+

紫杉醇单药周疗法二线治疗晚期胃癌的临床观察 被引量:3

下载PDF
导出
摘要 目的观察紫杉醇作为二线方案治疗晚期胃癌的有效性和安全性。方法紫杉醇80 mg/m^2第1天及第8天静脉滴注,21d为1个周期,连用2~6个周期。结果全组34例,CR 0例,PR 11例,SD 6例,PD 17例,总有效率32.4%,临床获益50.0%,毒副作用主要为Ⅰ~Ⅱ度中性粒细胞减少、脱水及周围神经损害。结论紫杉醇单药周疗法二线治疗晚期胃癌疗效肯定,安全性好。
出处 《中国厂矿医学》 2008年第4期404-405,共2页 Chinese Medicine of Factory and Mine
  • 相关文献

参考文献7

二级参考文献64

共引文献218

同被引文献16

  • 1王新林,王湘辉,张俊武.多西他赛联合卡铂治疗晚期胃癌[J].中国医院药学杂志,2006,26(11):1387-1388. 被引量:2
  • 2Wioson D, Hiller L, Geh JI, et al. Review of second-line chemotherapy for advanced gastric adenocarcinoma[J]. Chin Oncol( R Coil Radiol ) , 2005,17 (2) : 81.
  • 3周际昌,谢惠民.新编抗肿瘤药物临床治疗手册[M].北京:中国协和医科大学出版社,2009:388-389.
  • 4周际昌.实用肿瘤内科学[M].第2版.北京:人民卫生出版社,2005.386-388.
  • 5Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008 [ J ]. CA Cancer J Clin, 2008, 58:71-96.
  • 6Herrmann C, Jaeger D, Herrmann T. Second - line chemotherapy in advanced gastric cancer: a retrospective, single - center analysis [ J ]. Clin Oneol, 2007, 25: 15170.
  • 7Tsushima T, Hironaka S, Boku N, et al. Safety and efficacy of S - 1 monotherapy in elderly patients with advanced gastric cancer [ J]. Gas- tric Cancer, 2010, 13 (4): 245-250.
  • 8Park SH, Lee WK, Chung M, et al. Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial incombination with infusional 5 - fluorouracil [ J ]. Anticancer Drugs, 2006, 17 ( 2 ) : 225 - 229.
  • 9Lee JL, Kang YK, Kang HI, et al. A randomised multicentre phase I1 trial of capecitabine vs. S - 1 as first line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer [ J ]. Br J Canc- er, 2008, 99 (4): 584-590.
  • 10Fujitani K, Takiuehi H, Sugimoto N, et al. A randomized phase 1/ trial of S1 plus irinotecan versus S1 plus paclitaxel in advanced gastric cancer as a first - line treatment (OGSG0402) [ M ]. Gastrointestinal Cancers Symposium, 2009.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部